Effects of caspofungin, tolcapone and other FDA-approved medications on MRSA susceptibility to vancomycin.
Saved in:
| Title: | Effects of caspofungin, tolcapone and other FDA-approved medications on MRSA susceptibility to vancomycin. |
|---|---|
| Authors: | Moore JA; Department of Pharmaceutical Science and Research, School of Pharmacy, Marshall University, One John Marshall Drive, Huntington, WV 25755, USA., Meakin M; Department of Pharmaceutical Science and Research, School of Pharmacy, Marshall University, One John Marshall Drive, Huntington, WV 25755, USA., Earl MH; Department of Pharmaceutical Science and Research, School of Pharmacy, Marshall University, One John Marshall Drive, Huntington, WV 25755, USA., Kummer TM; Department of Pharmaceutical Science and Research, School of Pharmacy, Marshall University, One John Marshall Drive, Huntington, WV 25755, USA., McAleer JP; Department of Pharmaceutical Science and Research, School of Pharmacy, Marshall University, One John Marshall Drive, Huntington, WV 25755, USA., Long TE; Department of Pharmaceutical Science and Research, School of Pharmacy, Marshall University, One John Marshall Drive, Huntington, WV 25755, USA; Department of Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, One John Marshall Drive, Huntington, WV 25755, USA. Electronic address: longt@marshall.edu. |
| Source: | Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2020 Sep; Vol. 22, pp. 283-289. Date of Electronic Publication: 2020 Apr 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Published by Elsevier Ltd. on behalf of International Society of Chemotherapy for Infection and Cancer Country of Publication: Netherlands NLM ID: 101622459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-7173 (Electronic) Linking ISSN: 22137165 NLM ISO Abbreviation: J Glob Antimicrob Resist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
